These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3922630)

  • 21. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immunogenicity of a Mycobacterium tuberculosis subunit vaccine].
    Song NN; Wang BX; Shi DZ; Fu LF; Luo Y; Yu HJ; Han SB; Jiao L; Qie YQ; Wang HH; Zhang Y; Zhu BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):513-6. PubMed ID: 19954005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of lymphoid cells by components of BCG.
    Mitchell MS; Mokyr MB; Kahane I
    J Natl Cancer Inst; 1975 Dec; 55(6):1337-43. PubMed ID: 1107573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic lymphoid cells and antibodies from guinea pigs immunized with tubercle bacilli.
    Wasserman J; Packalén T; Perlmann P; Perlmann H
    Int Arch Allergy Appl Immunol; 1969; 36(1):115-6. PubMed ID: 4980285
    [No Abstract]   [Full Text] [Related]  

  • 25. Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli.
    Ben-Efraim S; Constantini-Sourojon M; Weiss DW
    Cell Immunol; 1973 Jun; 7(3):370-9. PubMed ID: 4198089
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The immunological responses induced by Mycobacterium tuberculosis heat shock protein 16.3 and its synthetic peptide in mice].
    Shi CH; Zhang TF; Zhu DS; Zhang H; Bai B; Zhao Y; Yue CL; Zhao L; Liu JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):603-7. PubMed ID: 19958680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.
    Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ
    Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Relationship of antigen dose to heightened primary and secondary immune responses to sheep red blood cells.
    Yashphe DJ
    Clin Exp Immunol; 1972 Dec; 12(4):497-506. PubMed ID: 4568152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in the mouse. I. In vitro enhancement of antibody formation with normal spleen cells.
    Murgo AJ; Athanassiades TJ
    J Immunol; 1975 Oct; 115(4):928-31. PubMed ID: 170337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvants and in vitro antibody production.
    Maillard JL; Bloom BR
    Adv Exp Med Biol; 1973; 29(0):567-71. PubMed ID: 4211780
    [No Abstract]   [Full Text] [Related]  

  • 33. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
    Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
    J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of immunological responsiveness by pretreatment with a methanol-insoluble fraction of killed tubercle bacilli.
    Yashphe DJ; Steinkuller CB; Weiss DW
    Isr J Med Sci; 1969; 5(2):2-66. PubMed ID: 5803761
    [No Abstract]   [Full Text] [Related]  

  • 35. A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice.
    Petricevich VL; Ueda C; Alves RC; da Silva MA; Moreno C; Melo AR; Dias da Silva W
    Braz J Med Biol Res; 2001 Jan; 34(1):81-92. PubMed ID: 11151032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    Kawahara M; Hasegawa N; Takaku H
    PLoS One; 2016; 11(3):e0152051. PubMed ID: 26999357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
    Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
    Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
    J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
    Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.